Drug discovery has become increasingly challenging and costly. Despite increasing investments in pharmaceutical research and development, the annual number of approvals has not risen since 1950. This could be due to a multitude of challenges including higher regulatory hurdles and greater complexity of diseases.
Learn how scientists in the drug discovery field search for the most promising lead compounds. Dr. Claire Hatty from NanoTemper will highlight case studies demonstrating the value of biophysical tools in drug discovery workflows. In the second half of the webinar, Dr. Jana Wolf from Domainex Ltd will explain how they apply those tools for their drug discovery projects.
Watch this webinar to discover how one multi-functional set of tools can:- Be exploited at various stages of early drug discovery
- Help to address key challenges
- Characterize and screen drug–target interactions
